InvestorsHub Logo

CashMoneyCarl

10/15/19 8:33 AM

#59135 RE: baldingcontrarian #59134

Good Morning Peeps..

I see our friend is back.. he is entitled to his opinion but I am also entitled to mine. Here is what I have to say about what he said..

Sales miss analysts numbers EVERY quarter


I know they have 'missed' some but not by much, and certainly not EVERY quarter. You can go back and look for yourself. Yet somehow, even these misses were record amounts for revenue. They may have missed, but they also have increased.

Joe was very confident about Nasdaq



So am I. Still.

The fact that nasdaq won’t take Cvsi s $ for listing should be a red flag.



Oh yee of little faith. Not one single US based CBD company has been accepted. Whatever the reason for the delay is not specific to CVSI, its all US based companies in our sector. But feel free to single CVSI out to make your point. I suspect this will change once the FDA comes out with their guidelines but of course, I am only speculating.

All for zero and huge costs of credibility



I am not real sure what it is you are trying to say here.. CVSI is probably one of, if not THE most credible company in the sector. All for zero? Obviously you are not talking about profits because CVSI is making them. Profits are greater than zero, even in Disneyland.

As for the rest of your statements, they are all pure speculation on your part. I don't know where you are getting your information from because you didn't bother to list any sources. What massive missed opportunities? What lapping?

The company is positioned rather nicely. Once the FDA waves the checkered flag then CVSI is going to be out front of the competition, even further than they already are. You are invited to sit back and watch for yourself.